Associations between the RAGE pathway and NAFLD have been suggested by multiple studies showing the hepatic and plasma/serum levels of RAGE ligands AGEs, ALEs, S100 and HMGB1, were enhanced in NAFLD vs. healthy controls (78–82). Here, S100B is linked to metabolic dysfunction-associated steatotic liver disease.